Amneal Pharmaceuticals (AMRX) Beginning Cash Balance (2018 - 2024)
Amneal Pharmaceuticals (AMRX) recorded quarterly Beginning Cash Balance of $32.7 million in Q3 2024, up 3170.4% quarter-over-quarter from $1.0 million in Q1 2021.
Amneal Pharmaceuticals (AMRX) Beginning Cash Balance (2018 - 2024) Analysis & Trends
Amneal Pharmaceuticals' Beginning Cash Balance history runs 3 years deep, the most recent figure standing at $32.7 million for Q3 2024.
- In Q3 2024, Beginning Cash Balance changed N/A year-over-year to $32.7 million; the TTM figure through Dec 2025 stood at $32.7 million (changed 0.0% YoY), while the FY2024 annual figure was $44.2 million, changed N/A from the prior year.
- Beginning Cash Balance was $32.7 million for Q3 2024 at Amneal Pharmaceuticals, up from $1.0 million in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $32.7 million in Q3 2024 to a low of $1.0 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Amneal Pharmaceuticals | 4.66 Bn | 4.65 Bn | 320.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 32.70 Mn |
| Sep 30, 2024 | 32.70 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2018 | 77.20 Mn |
| Dec 31, 2018 | 77.20 Mn |